Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +6.38% | +3.63% | -53.33% |
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Lewis Bender
CEO | Chief Executive Officer | 65 | 11-12-31 |
Joseph Talamo
DFI | Director of Finance/CFO | 55 | 12-10 |
John Wesolowski
AUD | Comptroller/Controller/Auditor | 65 | 17-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Goldberg
BRD | Director/Board Member | 64 | 18-04-30 |
Lewis Bender
CEO | Chief Executive Officer | 65 | 11-12-31 |
Emer Leahy
BRD | Director/Board Member | 58 | 16-05-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,709,377 | 8,344,671 ( 60.87 %) | 0 | 60.87 % |
Company contact information
Intensity Therapeutics, Inc.
1 Enterprise Drive Suite 430
06880, Shelton
+
http://www.intensitytherapeutics.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.33% | 54.84M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- INTS Stock
- Company Intensity Therapeutics, Inc.